Prelude Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $604k | 127k | 4.74 |
| 2023-12-31 | $533k | 125k | 4.27 |
| 2023-09-30 | $380k | 123k | 3.09 |
| 2023-06-30 | $386k | 86k | 4.50 |
| 2023-03-31 | $358k | 63k | 5.70 |
| 2022-12-31 | $385k | 64k | 6.04 |
| 2022-09-30 | $358k | 54k | 6.62 |
| 2022-06-30 | $330k | 63k | 5.22 |
| 2022-03-31 | $524k | 76k | 6.90 |
| 2021-12-31 | $1.1M | 85k | 12.45 |
| 2021-09-30 | $2.6M | 84k | 31.26 |
| 2021-06-30 | $2.1M | 73k | 28.64 |
| 2021-03-31 | $3.2M | 75k | 43.34 |
| 2020-12-31 | $4.9M | 69k | 71.56 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management